MNKD Message Board Post 9183200 | MannKind Corporation
home / stock / mnkd / mnkd message board
MBarrington01
(investorshub)
Posted on: Mar/09/2021 20:04:34
Source: investorshub
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=162442310
CEO acquiring more stock...hmmm
News, Short Squeeze, Breakout and More Instantly...
-
Pulmatrix Announces Cross License Agreement and Transfer of Laboratory to MannKind Corporation PR Newswire Cross license involves Pulmatrix iSPERSE™ technology and MannKind's Cricket ® inhalation device. Pulmatrix transferring leased building,...
-
Immediate opportunity to increase capacity for formulation and early asset development in upgraded Boston area R&D space Non-cash deal includes royalty-free iSPERSE ™ technology license in exchange for access to MannKind’s Cricket ® inhaler ...
-
2024-05-09 00:15:12 ET Image source: The Motley Fool. MannKind (NASDAQ: MNKD) Q1 2024 Earnings Call May 08, 2024 , 5:00 p.m. ET Operator Continue reading For further details see: MannKind (MNKD) Q1 2024 Earnings Call Transcript